Taiwan claims data study of 135 230 patients who received antineoplastic medications, found that immune checkpoint inhibitors use was associated with a 2-fold increased risk of developing psoriasis (HR 2.43).
https://t.co/m5eGT56W12 https://t.co/h5FjQpHOpF
Links:
Psoriasis Risk With Immune Checkpoint Inhibitors
https://buff.ly/4fFS5SU
Nov-11-2024


